| Last Action | 04/08/22: signed by Governor (Acts Ch. 154) | 
|---|---|
| Title | AN ACT relating to opioid antagonists designed to reverse the effects of an opioid overdose. | 
| Bill Documents | 
                        Acts Chapter 154 
                         Current/Final Introduced  | 
            
| Bill Request Number | 187 | 
| Sponsors | D. Douglas, R. Alvarado | 
| Summary of Original Version | Amend KRS 15.291, 217.177, and 217.186 to define "opioid antagonist" as naloxone or any United States Food and Drug Administration-approved opioid antagonist designed to reverse the effects of an opioid overdose; replace references to naloxone with opiod antagonist. | 
| Index Headings of Original Version | 
                            Drugs and Medicines - Opioid antagonist, overdose reversal  Health and Medical Services - Opioid antagonist, overdose reversal Pharmacists - Opioid antagonist, overdose reversal Physicians and Practitioners - Opioid antagonist, overdose reversal Substance Abuse - Opioid antagonist, overdose reversal Opioids - Opioid antagonist, overdose reversal  | 
            
| Jump to Proposed Amendments | Senate Floor Amendment 1 | 
| Votes | Vote History | 
| 01/06/22 | 
                    
  | 
            
|---|---|
| 01/10/22 | 
                    
  | 
            
| 01/12/22 | 
                    
  | 
            
| 01/13/22 | 
                    
  | 
            
| 01/18/22 | 
                    
  | 
            
| 01/19/22 | 
                    
  | 
            
| 01/20/22 | 
                    
  | 
            
| 03/09/22 | 
                    
  | 
            
| 03/17/22 | 
                    
  | 
            
| 03/18/22 | 
                    
  | 
            
| 03/22/22 | 
                    
  | 
            
| 03/29/22 | 
                    
  | 
            
| 03/30/22 | 
                    
  | 
            
| 04/08/22 | 
                    
  | 
            
| Amendment | Senate Floor Amendment 1 | 
|---|---|
| Sponsor | D. Douglas | 
| Summary | Retain original provisions of the bill; add provisions for providing an opioid antagonist as part of a harm reduction program; make technical corrections. | 
| Index Headings | 
                            Drugs and Medicines - Opioid antagonist, overdose reversal  Health and Medical Services - Opioid antagonist, overdose reversal Pharmacists - Opioid antagonist, overdose reversal Physicians and Practitioners - Opioid antagonist, overdose reversal Substance Abuse - Opioid antagonist, overdose reversal Opioids - Opioid antagonist, overdose reversal  | 
            
Last updated: 2/8/2023 2:57 PM (EST)